3 TSX Penny Stocks With Market Caps Over CA$20M To Watch

In This Article:

With Canada's election behind it, the focus has shifted towards economic growth and trade diversification, as policymakers aim to provide fiscal stimulus and potentially lower interest rates. In this context, investors are keenly observing opportunities that align with these broader economic themes. Although 'penny stocks' might seem like a term from a bygone era, they continue to offer intriguing potential for growth when backed by strong financials. We explore several such penny stocks on the TSX that stand out for their financial resilience and potential for significant returns.

Top 10 Penny Stocks In Canada

Name

Share Price

Market Cap

Financial Health Rating

Westbridge Renewable Energy (TSXV:WEB)

CA$0.80

CA$74.85M

★★★★★★

NTG Clarity Networks (TSXV:NCI)

CA$1.99

CA$73.2M

★★★★★★

Silvercorp Metals (TSX:SVM)

CA$4.97

CA$1.05B

★★★★★☆

Orezone Gold (TSX:ORE)

CA$1.13

CA$576.02M

★★★★★☆

Amerigo Resources (TSX:ARG)

CA$1.73

CA$280.6M

★★★★★☆

PetroTal (TSX:TAL)

CA$0.56

CA$503.49M

★★★★★☆

Pulse Seismic (TSX:PSD)

CA$2.50

CA$128.51M

★★★★★★

McCoy Global (TSX:MCB)

CA$3.12

CA$84.74M

★★★★★★

Findev (TSXV:FDI)

CA$0.465

CA$14.04M

★★★★★★

Enterprise Group (TSX:E)

CA$1.61

CA$116.3M

★★★★★☆

Click here to see the full list of 930 stocks from our TSX Penny Stocks screener.

Let's uncover some gems from our specialized screener.

Cronos Group

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Cronos Group Inc. is a cannabinoid company involved in the cultivation, production, distribution, and marketing of cannabis products across Canada, Israel, and internationally with a market cap of approximately CA$975.45 million.

Operations: The company generates revenue of $117.62 million from its cultivation, manufacture, and marketing of cannabis and cannabis-derived products segment.

Market Cap: CA$975.45M

Cronos Group Inc. has transitioned to profitability, reporting net income of US$43.73 million for the latest quarter, a significant turnaround from previous losses. Despite a low return on equity of 3.6%, its price-to-earnings ratio of 17.7x suggests it is valued below the industry average, potentially offering good value for investors interested in penny stocks. The company remains debt-free with substantial short-term assets covering liabilities, enhancing financial stability. Recent product launches in its Spinach®? brand and executive changes could influence future performance, though earnings are forecasted to decline over the next three years by an average of 21.6% annually.